|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 57.44 USD | -4.03% |
|
-3.46% | -30.07% |
| 16/07 | RxSight Names Aziz Mottiwala as CEO | MT |
| 14/07 | Tarsus Pharmaceuticals, Inc. Announces Management Changes, Effective July 13, 2026 | CI |
| Market Cap | 257.5Cr 225.03Cr 207.65Cr 191.4Cr 360.76Cr 25TCr 368.76Cr 2.48TCr 976.2Cr 12TCr 967.04Cr 945.82Cr 42TCr | P/E 2026 * |
-26.6x | P/E 2027 * | 36.1x |
|---|---|---|---|---|---|
| Enterprise Value | 257.5Cr 225.03Cr 207.65Cr 191.4Cr 360.76Cr 25TCr 368.76Cr 2.48TCr 976.2Cr 12TCr 967.04Cr 945.82Cr 42TCr | EV / Sales 2026 * |
3.62x | EV / Sales 2027 * | 2.86x |
| Free-Float |
96.94% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Tarsus Pharmaceuticals, Inc.
| 1 day | -4.52% | ||
| 1 week | -3.46% | ||
| Current month | -9.02% | ||
| 1 month | -9.91% | ||
| 3 months | -13.20% | ||
| 6 months | -19.27% | ||
| Current year | -30.07% |
| 1 week | 53.89 |  | 60.44 |
| 1 month | 53.89 | | 72.5 |
| Current year | 53.89 | | 83.92 |
| 1 year | 38.51 | | 85.25 |
| 3 years | 12.57 | | 85.25 |
| 5 years | 10.8 | | 85.25 |
| 10 years | 10.8 | | 85.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bobak Azamian
CEO | Chief Executive Officer | 48 | 01/09/2018 |
Jeffrey Farrow
DFI | Director of Finance/CFO | 64 | 24/04/2023 |
| Chief Tech/Sci/R&D Officer | 47 | 04/11/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
David Pyott
BRD | Director/Board Member | 72 | 18/02/2026 |
Bill Link
BRD | Director/Board Member | 80 | 01/01/2017 |
Wendy Yarno
BRD | Director/Board Member | 71 | 19/11/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 25/06/26 | Free | Director | 6,254 | 0.0145% | ||
| 25/06/26 | Free | Director | 7,060 | 0.0164% | ||
| 25/06/26 | Free | Director | 6,254 | 0.0145% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.03% | -3.46% | +35.75% | +146.39% | 257.5Cr | |
| +0.10% | +1.96% | +23.93% | -6.49% | 6.88TCr | |
| -0.54% | +1.02% | +37.33% | +189.96% | 5.21TCr | |
| -3.65% | +34.50% | +34.50% | +34.50% | 4.35TCr | |
| -0.58% | -0.23% | -52.36% | -53.82% | 4.12TCr | |
| -1.14% | -2.46% | +66.20% | -25.78% | 3.04TCr | |
| -0.75% | -8.30% | +98.42% | -50.75% | 2.45TCr | |
| -1.22% | +1.49% | +72.05% | +81.11% | 2.34TCr | |
| +3.99% | +3.12% | +3.87% | +200.81% | 1.98TCr | |
| +0.26% | +0.39% | +72.12% | +126.52% | 1.66TCr | |
| Average | -0.78% | -0.63% | +39.18% | +64.24% | 3.23TCr | |
| Weighted average by Cap. | -0.65% | -0.44% | +32.24% | +46.59% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 71Cr 62Cr 57Cr 53Cr 100Cr 6.85TCr 101.79Cr 685.11Cr 269.47Cr 3.35TCr 266.94Cr 261.08Cr 12TCr | 90Cr 79Cr 73Cr 67Cr 126.13Cr 8.67TCr 128.93Cr 867.77Cr 341.31Cr 4.25TCr 338.11Cr 330.69Cr 15TCr |
| Net income | -9.79Cr -8.56Cr -7.9Cr -7.28Cr -14Cr -942.92Cr -14Cr -94Cr -37Cr -461.8Cr -37Cr -36Cr -1.59TCr | 8.27Cr 7.23Cr 6.67Cr 6.15Cr 12Cr 796.62Cr 12Cr 80Cr 31Cr 390.15Cr 31Cr 30Cr 1.34TCr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/26/20 | $57.26 | -4.34% | 5,41,033 |
| 17/26/17 | $59.85 | +3.74% | 9,71,197 |
| 16/26/16 | $57.69 | +0.33% | 15,20,624 |
| 15/26/15 | $57.50 | +2.48% | 14,67,064 |
| 14/26/14 | $56.11 | -5.40% | 20,79,500 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TARS Stock
Select your edition
All financial news and data tailored to specific country editions
